SCHEMBL26435527

SCHEMBL26435527

c1cc(-c2nc(-c3ccc(-c4ccc5sc6ccccc6c5c4)cc3)nc(-c3ccc4oc5ccccc5c4c3)n2)cc(-c2cccc3ccc4ccccc4c23)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.33
MAPK1 P28482 2/20 0.33
ABCG2 Q9UNQ0 4/20 0.33
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
MAPT P10636 4/20 0.33
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
PLA2G10 O15496 1/20 0.33
CYP1A1 P04798 1/20 0.32
CYP1A2 P05177 1/20 0.32
FYN P06241 1/20 0.32
MAPK3 P27361 1/20 0.32
AHR P35869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435481 0.92 KMT2A (0.34) KMT2AMAPK1ABCG2KDM4EALDH1A1
SCHEMBL26435483 0.90 TDP1 (0.33) KMT2AMAPK1ABCG2KDM4EALDH1A1
SCHEMBL26435530 0.89 ALOX5 (0.42) KMT2AMAPK1ABCG2KDM4EALDH1A1
SCHEMBL26217255 0.89 S1PR5 (0.32) KMT2AMAPK1KDM4EALDH1A1MAPT
SCHEMBL19802562 0.89 MAPK1 (0.36) KMT2AMAPK1ABCG2KDM4EALDH1A1
SCHEMBL26435393 0.89 PRKDC (0.33) KMT2AABCG2ALDH1A1AHRMEN1
SCHEMBL26435348 0.89 ABCG2 (0.33) KMT2AMAPK1ABCG2KDM4EALDH1A1
SCHEMBL25459528 0.89 PLA2G2A (0.38) ALDH1A1PLA2G2APLA2G4AHPGDPLA2G10
SCHEMBL22876364 0.89 PLA2G2A (0.38) ALDH1A1PLA2G2APLA2G4AHPGDPLA2G10
SCHEMBL26435469 0.89 ABCG2 (0.40) KMT2AMAPK1ABCG2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 KMT2A 2391/4885MAPK1 536/4885ABCG2 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.